ECM
VIE

ExodusPoint Capital Management’s Viela Bio, Inc. Common Stock VIE Stock Holding History

ExodusPoint Capital Management’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28,193
Closed -$1.07M – 2140
2020
Q1 		$1.07M Buy
+28,193
New +$1.1M 0.06% 294

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ExodusPoint Capital Management's VIE Position: Q2 2020 in Review

ExodusPoint Capital Management sold out of Viela Bio, Inc. Common Stock (VIE) in Q2 2020, closing a stake of 28,193 shares — an estimated $1.07M sold.

ExodusPoint Capital Management first reported a position in VIE in Q1 2020 and held it in 1 quarter. The position peaked at $1.07M in Q1 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q2 2020.

  • ExodusPoint Capital Management reported no remaining Viela Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 28,193 Viela Bio, Inc. Common Stock shares in Q2 2020, an estimated $1.07M.
  • ExodusPoint Capital Management first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • ExodusPoint Capital Management's Viela Bio, Inc. Common Stock position peaked at $1.07M in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.